Summitry LLC Novartis Ag Transaction History

Summitry LLC

$1.94 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$74.61 - $87.26 $168,543 - $197,120	2,259 Added 7.03%	34,393 $2.61 Million
Q2 2022 Aug 09, 2022	SELL	$80.52 - $93.75 $216,196 - $251,718	-2,685 Reduced 7.71%	32,134 $2.72 Million
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $61,444 - $69,505	-767 Reduced 2.16%	34,819 $3.06 Million
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $107,515 - $118,887	1,349 Added 3.94%	35,586 $3.11 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $36,228 - $42,147	-443 Reduced 1.28%	34,237 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $202,018 - $223,135	2,370 Added 7.34%	34,680 $3.16 Million
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $152,972 - $180,397	1,832 Added 6.01%	32,310 $2.76 Million
Q4 2020 Feb 05, 2021	BUY	$78.07 - $94.43 $57,069 - $69,028	731 Added 2.46%	30,478 $2.88 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $29,159 - $32,305	355 Added 1.21%	29,747 $2.59 Million
Q2 2020 Aug 07, 2020	BUY	$80.93 - $91.1 $186,139 - $209,530	2,300 Added 8.49%	29,392 $2.57 Million
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $72,012 - $100,891	1,019 Added 3.91%	27,092 $2.23 Million
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $175,026 - $197,892	2,075 Added 8.65%	26,073 $2.47 Million
Q3 2019 Nov 05, 2019	BUY	$85.54 - $94.26 $50,468 - $55,613	590 Added 2.52%	23,998 $2.09 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $15.7 Million - $19.3 Million	-208,125 Reduced 89.89%	23,408 $2.14 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $12.9 Million - $14.7 Million	-170,829 Reduced 42.46%	231,533 $22.3 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $4.33 Million - $4.82 Million	-58,809 Reduced 12.75%	402,362 $34.5 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $72,094 - $83,392	1,077 Added 0.23%	461,171 $39.7 Million
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $228,418 - $258,153	3,519 Added 0.77%	460,094 $34.8 Million
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $51,173 - $61,177	-727 Reduced 0.16%	456,575 $36.9 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $308,704 - $331,367	4,268 Added 0.94%	457,302 $38.4 Million
Q3 2017 Nov 02, 2017	BUY	$74.14 - $77.27 $33.6 Million - $35 Million	453,034	453,034 $38.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.

Account